Kevin O’Leary Rejects Fed Rate Cut Impact on Bitcoin
- Kevin O’Leary downplays a December rate cut impact.
- Expects Bitcoin to remain within a 5% price range.
- Market holds 89% probability for rate cut decision.
Kevin O’Leary anticipates minimal Bitcoin price fluctuation with the expected Federal Reserve rate decision in December. Despite market predictions for a rate cut, he cites persistent inflation as a factor maintaining Bitcoin’s steady trajectory within a 5% range.
In a recent commentary, Kevin O’Leary, a notable entrepreneur and investor, stated that a Federal Reserve rate cut in December would not significantly impact Bitcoin’s price. This perspective was shared during his interview discussions with financial outlets.
The statement holds importance as it contrasts with market expectations which largely favor a rate cut. O’Leary emphasizes limited price movement due to ongoing inflationary pressures.
As a prominent voice in crypto investing, Kevin O’Leary has expressed skepticism about the Federal Reserve’s potential rate cut in December. He anticipates that Bitcoin’s price will generally remain stable, within a 5% range of its current level, regardless of the cut.
Despite a nearly 89% probability of a December rate cut indicated by the CME FedWatch Tool, O’Leary remains convinced that inflationary pressures will lead the Fed to adopt a cautious stance. These statements differ substantially from the market’s dominant narrative.
Bitcoin, often viewed as a hedge against traditional financial shifts, might seem immune to these changes according to O’Leary’s perspective. However, the broader implications of a rate cut typically drive investors toward risk assets.
Historically, rate cuts correlated with increased risk appetite, affecting cryptocurrencies. However, O’Leary argues that current economic conditions reduce these influences. Consequently, Bitcoin is not poised for significant price shifts in response to the possible December Fed decision.
You May Also Like
Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution
